Clinical Trial Update: Etanercept Plus Methotrexate Versus Methotrexate Alone in Children With Polyarticular Course Juvenile Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing etanercept plus methotrexate versus methotrexate alone in children with polyarticular-course juvenile rheumatoid arthritis; trial termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis

Drugs mentioned

• Etanercept (etanercept)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Amgen | Conditions: Juvenile Rheumatoid Arthritis | Phase 3 | Status: TERMINATED | Results posted: 2019-08-02